Indication
Proteus pneumonia
Proteus pneumonia is a bacterial lower respiratory tract infection of the lung parenchyma caused by members of the Gram-negative genus *Proteus*, most commonly *Proteus mirabilis*. Read more about Proteus pneumonia
174 drugs 86 manufacturers
Drugs that treat it
Common Proteus pneumonia therapies.
GENTAMICIN SULFATE (gentamicin sulfate/PF)
CLAFORAN (cefotaxime sodium)
CEFOTETAN (cefotetan disodium)
CEFTRIAXONE (ceftriaxone sodium)
AMIKACIN SULFATE
CEFOTETAN (cefotetan disodium)
CIPROFLOXACIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonProteus pneumonia is a bacterial lower respiratory tract infection of the lung parenchyma caused by members of the Gram-negative genus *Proteus*, most commonly *Proteus mirabilis*.
It predominantly affects hospitalized, debilitated, or immunocompromised patients, particularly older adults, individuals with chronic pulmonary or neurological diseases, and those prone to microaspiration or requiring mechanical ventilation.
Pathophysiologically, the organism colonizes the respiratory tract via aspiration of oropharyngeal secretions or hematogenous seeding from an extrapulmonary site, such as an infected urinary tract.
The infection typically manifests with fever, productive cough, dyspnea, hypoxemia, and pulmonary consolidation on chest radiography, with severe presentations potentially complicated by necrotizing tissue damage, abscess formation, or systemic bacteremia.
- nih.gov
Proteus pneumonia is a bacterial lower respiratory tract infection of the lung parenchyma caused by members of the Gram-negative genus *Proteus*, most commonly *Proteus mirabilis* It predominantly affects hospitalized, debilitated, or immunocompromised patients, particularly older adults, individuals with chronic pulmonary or neurological diseases, and those prone to microaspiration or requiring mechanical ventilation
- termbrowser.nhs.uk
Proteus pneumonia is a bacterial lower respiratory tract infection of the lung parenchyma caused by members of the Gram-negative genus *Proteus*, most commonly *Proteus mirabilis* The infection typically manifests with fever, productive cough, dyspnea, hypoxemia, and pulmonary consolidation on chest radiography, with severe presentations potentially complicated by necrotizing tissue damage, abscess formation, or systemic bacteremia
- nih.gov
It predominantly affects hospitalized, debilitated, or immunocompromised patients, particularly older adults, individuals with chronic pulmonary or neurological diseases, and those prone to microaspiration or requiring mechanical ventilation Pathophysiologically, the organism colonizes the respiratory tract via aspiration of oropharyngeal secretions or hematogenous seeding from an extrapulmonary site, such as an infected urinary tract
- acpjournals.org
It predominantly affects hospitalized, debilitated, or immunocompromised patients, particularly older adults, individuals with chronic pulmonary or neurological diseases, and those prone to microaspiration or requiring mechanical ventilation Pathophysiologically, the organism colonizes the respiratory tract via aspiration of oropharyngeal secretions or hematogenous seeding from an extrapulmonary site, such as an infected urinary tract The infection typically manifests with fever, productive coug...
- merckmanuals.com
The infection typically manifests with fever, productive cough, dyspnea, hypoxemia, and pulmonary consolidation on chest radiography, with severe presentations potentially complicated by necrotizing tissue damage, abscess formation, or systemic bacteremia
- emc.id
The infection typically manifests with fever, productive cough, dyspnea, hypoxemia, and pulmonary consolidation on chest radiography, with severe presentations potentially complicated by necrotizing tissue damage, abscess formation, or systemic bacteremia
Personalize your experience
Follow Proteus pneumonia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.